CGAS and colorectal cancer: In conclusion, the inexpensive clinical drug ciprofloxacin, a fluoroquinolone-class antibiotic, may activate the cGAS-STING signaling pathway and enhance the anti-PD1 therapeutic effects in colorectal cancer.